These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 32314875)

  • 1. Risk of intracranial bleeding in patients with primary brain cancer receiving therapeutic anticoagulation for venous thromboembolism: A meta-analysis.
    Porfidia A; Giordano M; Sturiale CL; D'Arrigo S; Donadini MP; Olivi A; Ageno W; Pola R
    Brain Behav; 2020 Jun; 10(6):e01638. PubMed ID: 32314875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A meta-analysis of intracranial hemorrhage in patients with brain tumors receiving therapeutic anticoagulation.
    Zwicker JI; Karp Leaf R; Carrier M
    J Thromb Haemost; 2016 Sep; 14(9):1736-40. PubMed ID: 27306689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of venous thromboembolism in high-grade glioma: Does low molecular weight heparin increase intracranial bleeding risk?
    Jo J; Donahue J; Sarai G; Petroni G; Schiff D
    Neuro Oncol; 2022 Mar; 24(3):455-464. PubMed ID: 34383073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of intracranial hemorrhage associated with therapeutic anticoagulation for venous thromboembolism in cancer patients: a systematic review and meta-analysis.
    Rojas-Hernandez CM; Oo TH; García-Perdomo HA
    J Thromb Thrombolysis; 2017 Feb; 43(2):233-240. PubMed ID: 27704333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of direct oral anticoagulants versus low-molecular-weight heparin in primary and metastatic brain cancers: a meta-analysis and systematic review.
    Iyengar V; Agrawal S; Chiasakul T; Tehranchi K; Mcnichol M; Carney BJ; Leader A; Zwicker JI; Patell R
    J Thromb Haemost; 2024 Feb; 22(2):423-429. PubMed ID: 37866517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk of intracranial hemorrhage in glioma patients receiving anticoagulant treatment for venous thromboembolism: a bayesian network meta-analysis.
    Huo H; Shen S; Yang Y; Zhang H; Wu S; Bi T; Li Y
    J Thromb Thrombolysis; 2023 Aug; 56(2):333-341. PubMed ID: 37341895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of intracranial hemorrhage with direct oral anticoagulation versus low molecular weight heparin in the treatment of brain tumor-associated venous thromboembolism: A meta-analysis.
    Yang J; He Z; Li M; Hong T; Ouyang T
    J Stroke Cerebrovasc Dis; 2023 Aug; 32(8):107243. PubMed ID: 37413715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic anticoagulation for venous thromboembolism after recent brain surgery: Evaluating the risk of intracranial hemorrhage.
    de Melo Junior JO; Lodi Campos Melo MA; da Silva Lavradas LA; Ferreira Lopes PG; Luiz Ornelas II; de Barros PL; da Mata Pereira PJ; Niemeyer Filho P
    Clin Neurol Neurosurg; 2020 Oct; 197():106202. PubMed ID: 32916398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracranial hemorrhage with direct oral anticoagulants in patients with brain tumors.
    Carney BJ; Uhlmann EJ; Puligandla M; Mantia C; Weber GM; Neuberg DS; Zwicker JI
    J Thromb Haemost; 2019 Jan; 17(1):72-76. PubMed ID: 30450803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of intracranial hemorrhage with anticoagulation therapy in melanoma patients with brain metastases.
    Alvarado G; Noor R; Bassett R; Papadopoulos NE; Kim KB; Hwu WJ; Bedikian A; Patel S; Hwu P; Davies MA
    Melanoma Res; 2012 Aug; 22(4):310-5. PubMed ID: 22584956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous Thrombotic Events and Anticoagulation in Brain Tumor Patients.
    Diaz M; Jo J
    Curr Oncol Rep; 2022 Apr; 24(4):493-500. PubMed ID: 35179708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of low-molecular-weight heparin treatment for venous thromboembolism in patients with primary and metastatic brain tumours.
    Chai-Adisaksopha C; Linkins LA; ALKindi SY; Cheah M; Crowther MA; Iorio A
    Thromb Haemost; 2017 Feb; 117(3):589-594. PubMed ID: 28078351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulation in the Setting of Primary and Metastatic Brain Tumors.
    Mantia C; Zwicker JI
    Cancer Treat Res; 2019; 179():179-189. PubMed ID: 31317488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting the higher rate of intracranial hemorrhage in glioma patients receiving therapeutic enoxaparin.
    Mantia C; Uhlmann EJ; Puligandla M; Weber GM; Neuberg D; Zwicker JI
    Blood; 2017 Jun; 129(25):3379-3385. PubMed ID: 28468796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism.
    Robertson L; Strachan J
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD006771. PubMed ID: 28195640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of venous thromboembolism in patients with glioma.
    Al Megren M; De Wit C; Al Qahtani M; Le Gal G; Carrier M
    Thromb Res; 2017 Aug; 156():105-108. PubMed ID: 28624717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of intracranial hemorrhage with direct oral anticoagulants vs low molecular weight heparin in glioblastoma: A retrospective cohort study.
    Reed-Guy L; Desai AS; Phillips RE; Croteau D; Albright K; O'Neill M; Brem S; O'Rourke DM; Amankulor NM; Bagley SJ
    Neuro Oncol; 2022 Dec; 24(12):2172-2179. PubMed ID: 35551405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer.
    Akl EA; Kahale L; Barba M; Neumann I; Labedi N; Terrenato I; Sperati F; Muti P; Schünemann H
    Cochrane Database Syst Rev; 2014 Jul; (7):CD006650. PubMed ID: 25004410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulant Management and Outcomes in Nontraumatic Intracranial Hemorrhage Complicated by Venous Thromboembolism: A Retrospective Chart Review.
    Gorman J; Candeloro M; Schulman S
    Thromb Haemost; 2023 Oct; 123(10):966-975. PubMed ID: 37015326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Anticoagulation in Patients with Primary Brain Tumors or Secondary Brain Metastasis.
    Lin RJ; Green DL; Shah GL
    Oncologist; 2018 Apr; 23(4):468-473. PubMed ID: 29158366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.